Oxford, Silicon Valley Provide Financing to Vitae Pharmaceuticals
Oxford Finance announced a $15 million round of debt financing for Vitae Pharmaceuticals. The senior credit facility was awarded to Vitae from both Oxford and Silicon Valley Bank. The funds will be used to support the progress of Vitae’s drug treatment pipeline.